Cargando…
Autoregressive Modeling and Prediction of the Activity of Antihypertensive Peptides
Naturally derived bioactive peptides with antihypertensive activities serve as promising alternatives to pharmaceutical drugs. There are few relevant reports on the mapping relationship between the EC(50) value of antihypertensive peptide activity (AHTPA-EC(50)) and its corresponding amino acid sequ...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8787326/ https://www.ncbi.nlm.nih.gov/pubmed/35087574 http://dx.doi.org/10.3389/fgene.2021.801728 |
_version_ | 1784639337834479616 |
---|---|
author | Xie, Xufen Zhu, Chuanchuan Wu, Di Du, Ming |
author_facet | Xie, Xufen Zhu, Chuanchuan Wu, Di Du, Ming |
author_sort | Xie, Xufen |
collection | PubMed |
description | Naturally derived bioactive peptides with antihypertensive activities serve as promising alternatives to pharmaceutical drugs. There are few relevant reports on the mapping relationship between the EC(50) value of antihypertensive peptide activity (AHTPA-EC(50)) and its corresponding amino acid sequence (AAS) at present. In this paper, we have constructed two group series based on sorting natural logarithm of AHTPA-EC(50) or sorting its corresponding AAS encoding number. One group possesses two series, and we find that there must be a random number series in any group series. The random number series manifests fractal characteristics, and the constructed series of sorting natural logarithm of AHTPA-EC(50) shows good autocorrelation characteristics. Therefore, two non-linear autoregressive models with exogenous input (NARXs) were established to describe the two series. A prediction method is further designed for AHTPA-EC(50) prediction based on the proposed model. Two dynamic neural networks for NARXs (NARXNNs) are designed to verify the two series characteristics. Dipeptides and tripeptides are used to verify the proposed prediction method. The results show that the mean square error (MSE) of prediction is about 0.5589 for AHTPA-EC(50) prediction when the classification of AAS is correct. The proposed method provides a solution for AHTPA-EC(50) prediction. |
format | Online Article Text |
id | pubmed-8787326 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-87873262022-01-26 Autoregressive Modeling and Prediction of the Activity of Antihypertensive Peptides Xie, Xufen Zhu, Chuanchuan Wu, Di Du, Ming Front Genet Genetics Naturally derived bioactive peptides with antihypertensive activities serve as promising alternatives to pharmaceutical drugs. There are few relevant reports on the mapping relationship between the EC(50) value of antihypertensive peptide activity (AHTPA-EC(50)) and its corresponding amino acid sequence (AAS) at present. In this paper, we have constructed two group series based on sorting natural logarithm of AHTPA-EC(50) or sorting its corresponding AAS encoding number. One group possesses two series, and we find that there must be a random number series in any group series. The random number series manifests fractal characteristics, and the constructed series of sorting natural logarithm of AHTPA-EC(50) shows good autocorrelation characteristics. Therefore, two non-linear autoregressive models with exogenous input (NARXs) were established to describe the two series. A prediction method is further designed for AHTPA-EC(50) prediction based on the proposed model. Two dynamic neural networks for NARXs (NARXNNs) are designed to verify the two series characteristics. Dipeptides and tripeptides are used to verify the proposed prediction method. The results show that the mean square error (MSE) of prediction is about 0.5589 for AHTPA-EC(50) prediction when the classification of AAS is correct. The proposed method provides a solution for AHTPA-EC(50) prediction. Frontiers Media S.A. 2022-01-11 /pmc/articles/PMC8787326/ /pubmed/35087574 http://dx.doi.org/10.3389/fgene.2021.801728 Text en Copyright © 2022 Xie, Zhu, Wu and Du. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Genetics Xie, Xufen Zhu, Chuanchuan Wu, Di Du, Ming Autoregressive Modeling and Prediction of the Activity of Antihypertensive Peptides |
title | Autoregressive Modeling and Prediction of the Activity of Antihypertensive Peptides |
title_full | Autoregressive Modeling and Prediction of the Activity of Antihypertensive Peptides |
title_fullStr | Autoregressive Modeling and Prediction of the Activity of Antihypertensive Peptides |
title_full_unstemmed | Autoregressive Modeling and Prediction of the Activity of Antihypertensive Peptides |
title_short | Autoregressive Modeling and Prediction of the Activity of Antihypertensive Peptides |
title_sort | autoregressive modeling and prediction of the activity of antihypertensive peptides |
topic | Genetics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8787326/ https://www.ncbi.nlm.nih.gov/pubmed/35087574 http://dx.doi.org/10.3389/fgene.2021.801728 |
work_keys_str_mv | AT xiexufen autoregressivemodelingandpredictionoftheactivityofantihypertensivepeptides AT zhuchuanchuan autoregressivemodelingandpredictionoftheactivityofantihypertensivepeptides AT wudi autoregressivemodelingandpredictionoftheactivityofantihypertensivepeptides AT duming autoregressivemodelingandpredictionoftheactivityofantihypertensivepeptides |